454 related articles for article (PubMed ID: 29775888)
1. Therapeutic impact of rHuEPO on abnormal platelet APP, BACE 1, presenilin 1, ADAM 10 and Aβ expressions in chronic kidney disease patients with cognitive dysfunction like Alzheimer's disease: A pilot study.
G V; S K; Sureshkumar ; G S; S S; Preethikrishnan ; S D; A S; D B; Riya ; P V
Biomed Pharmacother; 2018 Aug; 104():211-222. PubMed ID: 29775888
[TBL] [Abstract][Full Text] [Related]
2. Correlation between abnormal GSK3β, β Amyloid, total Tau, p-Tau 181 levels and neuropsychological assessment total scores in CKD patients with cognitive dysfunction: Impact of rHuEPO therapy.
Vinothkumar G; Krishnakumar S; Riya ; Venkataraman P
J Clin Neurosci; 2019 Nov; 69():38-42. PubMed ID: 31447360
[TBL] [Abstract][Full Text] [Related]
3. Berberine Alleviates Amyloid-Beta Pathology in the Brain of APP/PS1 Transgenic Mice via Inhibiting β/γ-Secretases Activity and Enhancing α-Secretases.
Cai Z; Wang C; He W; Chen Y
Curr Alzheimer Res; 2018; 15(11):1045-1052. PubMed ID: 29962345
[TBL] [Abstract][Full Text] [Related]
4. Effects of Folic Acid on Secretases Involved in Aβ Deposition in APP/PS1 Mice.
Tian T; Bai D; Li W; Huang GW; Liu H
Nutrients; 2016 Sep; 8(9):. PubMed ID: 27618097
[TBL] [Abstract][Full Text] [Related]
5. Protein Expression of BACE1 is Downregulated by Donepezil in Alzheimer's Disease Platelets.
Sarno TA; Talib LL; Joaquim HP; Bram JM; Gattaz WF; Forlenza OV
J Alzheimers Dis; 2017; 55(4):1445-1451. PubMed ID: 27858713
[TBL] [Abstract][Full Text] [Related]
6. Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets.
Evin G; Zhu A; Holsinger RM; Masters CL; Li QX
J Neurosci Res; 2003 Nov; 74(3):386-92. PubMed ID: 14598315
[TBL] [Abstract][Full Text] [Related]
7. Mitochondria are devoid of amyloid β-protein (Aβ)-producing secretases: Evidence for unlikely occurrence within mitochondria of Aβ generation from amyloid precursor protein.
Mamada N; Tanokashira D; Ishii K; Tamaoka A; Araki W
Biochem Biophys Res Commun; 2017 Apr; 486(2):321-328. PubMed ID: 28302486
[TBL] [Abstract][Full Text] [Related]
8. Notoginseng Saponin Rg1 Prevents Cognitive Impairment through Modulating APP Processing in Aβ
Liu SZ; Cheng W; Shao JW; Gu YF; Zhu YY; Dong QJ; Bai SY; Wang P; Lin L
Curr Med Sci; 2019 Apr; 39(2):196-203. PubMed ID: 31016510
[TBL] [Abstract][Full Text] [Related]
9. BACE1: the beta-secretase enzyme in Alzheimer's disease.
Vassar R
J Mol Neurosci; 2004; 23(1-2):105-14. PubMed ID: 15126696
[TBL] [Abstract][Full Text] [Related]
10. Gallic acid is a dual α/β-secretase modulator that reverses cognitive impairment and remediates pathology in Alzheimer mice.
Mori T; Koyama N; Yokoo T; Segawa T; Maeda M; Sawmiller D; Tan J; Town T
J Biol Chem; 2020 Nov; 295(48):16251-16266. PubMed ID: 32913125
[TBL] [Abstract][Full Text] [Related]
11. [Effects of huannao yicong recipe extract on the learning and memory and related factors of Abeta generation in the brain of APP transgenic mice].
Li H; Liu MF; Liu JG; Liu LT; Guan J; Cai LL; Hu J; Wei Y
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Jan; 33(1):90-4. PubMed ID: 23596795
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
13. Abnormal amyloid β
Vinothkumar G; Kedharnath C; Krishnakumar S; Sreedhar S; Preethikrishnan K; Dinesh S; Sundaram A; Balakrishnan D; Shivashekar G; Sureshkumar ; Venkataraman P
BBA Clin; 2017 Dec; 8():20-27. PubMed ID: 28702365
[TBL] [Abstract][Full Text] [Related]
14. Alpha-Linolenic Acid from Perilla frutescens var. japonica Oil Protects Aβ-Induced Cognitive Impairment through Regulation of APP Processing and Aβ Degradation.
Lee AY; Lee MH; Lee S; Cho EJ
J Agric Food Chem; 2017 Dec; 65(49):10719-10729. PubMed ID: 29092397
[TBL] [Abstract][Full Text] [Related]
15. Platelet amyloid precursor protein processing: a bio-marker for Alzheimer's disease.
Tang K; Hynan LS; Baskin F; Rosenberg RN
J Neurol Sci; 2006 Jan; 240(1-2):53-8. PubMed ID: 16256140
[TBL] [Abstract][Full Text] [Related]
16. OAB-14, a bexarotene derivative, improves Alzheimer's disease-related pathologies and cognitive impairments by increasing β-amyloid clearance in APP/PS1 mice.
Yuan C; Guo X; Zhou Q; Du F; Jiang W; Zhou X; Liu P; Chi T; Ji X; Gao J; Chen C; Lang H; Xu J; Liu D; Yang Y; Qiu S; Tang X; Chen G; Zou L
Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):161-180. PubMed ID: 30389579
[TBL] [Abstract][Full Text] [Related]
17. [Effect of βsheet blocking peptide H102 on APP metabolic enzymes in hippocampal brain of double transgenic AD mice].
Jiang F; Sun FX; Xu SM
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2017 Apr; 33(4):299-303. PubMed ID: 29926633
[TBL] [Abstract][Full Text] [Related]
18. Beta-secretase/BACE1 promotes APP endocytosis and processing in the endosomes and on cell membrane.
Wang M; Jing T; Wang X; Yao D
Neurosci Lett; 2018 Oct; 685():63-67. PubMed ID: 30120949
[TBL] [Abstract][Full Text] [Related]
19. Processing of the platelet amyloid precursor protein in the mild cognitive impairment (MCI).
Bermejo-Bescós P; Martín-Aragón S; Jiménez-Aliaga K; Benedí J; Felici E; Gil P; Ribera JM; Villar AM
Neurochem Res; 2013 Jul; 38(7):1415-23. PubMed ID: 23575575
[TBL] [Abstract][Full Text] [Related]
20. The beta-secretase, BACE: a prime drug target for Alzheimer's disease.
Vassar R
J Mol Neurosci; 2001 Oct; 17(2):157-70. PubMed ID: 11816789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]